Daytrana: Is It Ready for Prime Time? July 2006 Carol E. Watkins, M.D. Return to our ADHD Home Page Shire Pharmaceuticals recently released Daytrana for the treatment of AD/HD in children aged 6-12. Daytrana, previously known as the Methypatch, was developed based on technology from Noven Pharmaceuticals. The active ingredient, methylphenidate is the same chemical …

Daytrana Read More »